Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Resorcinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.47 |
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.47 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144371 | 0.94 | EGFR (0.67) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL94484 | 0.94 | EGFR (0.67) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL29555012 | 0.94 | EGFR (0.67) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL29378452 | 0.81 | EGFR (0.69) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL112101 | 0.81 | EGFR (0.69) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL112102 | 0.81 | EGFR (0.69) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL29635269 | 0.80 | EGFR (0.49) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL2440064 | 0.80 | EGFR (0.49) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL2440067 | 0.80 | EGFR (0.49) | EGFRMAPTMEN1KMT2APOLB | |
| SCHEMBL144370 | 0.80 | EGFR (0.67) | EGFRMAPTMEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160303544-A1 | METHOD OF MAKING A METALLIC COMPOSITE AND USE THEREOF | PORTLAND STATE UNIVERSITY (US) | 2016-10-20 | — | — | US | claimed |
| US-20260145971-A1 | METHOD OF WATER PURIFICATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-28 | — | — | US | disclosed |
| US-20260132059-A1 | HYDROGEN BONDING STABILIZED POLYARYL ORGANIC SOLVENT NANOFILTRATION MEMBRANE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-05-14 | — | — | US | disclosed |
| US-12611653-B1 | Nanocomposite for degrading organic contaminants | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-04-28 | — | — | US | disclosed |
| US-20260097386-A1 | MULTI-NANOCOMPOSITE FOR WATER DECONTAMINATION | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2026-04-09 | — | — | US | disclosed |
| US-12590018-B1 | Nanocomposite for wastewater treatment | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-03-31 | — | — | US | disclosed |
| US-12582972-B1 | Zirconium dioxide/calcium silicate/graphitic carbon nitride nanocomposite and method of use as a photocatalyst | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-03-24 | — | — | US | disclosed |
| EP-4709802-A1 | ALKYLPHENOL ETHOXYLATE FREE COLOR COMPOSITIONS | Dow Global Technologies LLC (US) | 2026-03-18 | — | — | EP | disclosed |
| US-12570547-B1 | Copper hydroxide nitrate/calcium silicate/graphitic carbon nitride nanocomposite material based absorbent for wastewater treatment | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12558666-B1 | Removal of water pollutant using calcium metavanadate/calcium silicate/graphite-phase carbon nitride (CaV2O6/CaSiO3/g-C3N4) nanocomposite | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2026-02-24 | — | — | US | disclosed |
| US-20110053076-A1 | SUPERCRITICAL FLUID MICROENCAPSULATION OF DYE INTO LATEX FOR IMPROVED EMULSION AGGREGATION TONER | XEROX CORPORATION (US) | 2011-03-03 | — | — | US | disclosed |
| EP-2289981-A2 | Supercritical fluid microencapsulation of dye into latex for emulsion aggregation toner | Xerox Corporation (US) | 2011-03-02 | — | — | EP | disclosed |
| EP-2240497-A1 | USE OF SULFONATED DYE SALT FOR MODULATING DYE STABILITY | Silverbrook Research Pty. Ltd (AU) | 2010-10-20 | — | — | EP | disclosed |
| US-20100003470-A1 | INKJET DYES EXHIBITING REDUCED KOGATION | SILVERBROOK RESEARCH PTY LTD | 2010-01-07 | — | — | US | disclosed |
| WO-2010000015-A1 | INKJET DYES EXHIBITING REDUCED KOGATION | SILVERBROOK RESEARCH PTY LTD (AU) | 2010-01-07 | — | — | WO | disclosed |
| US-20090297668-A1 | System and Methods for Automatic Preparation of Substitute Food Items | CANTU HOMARO R | 2009-12-03 | — | — | US | disclosed |
| WO-2009100480-A1 | USE OF SULFONATED DYE SALT FOR MODULATING DYE STABILITY | SILVERBROOK RESEARCH PTY LTD (AU) | 2009-08-20 | — | — | WO | disclosed |
| US-20090202799-A1 | SULFONATED DYE SALTS HAVING IMPROVED STABILITY | SILVERBROOK RESEARCH PTY LTD | 2009-08-13 | — | — | US | disclosed |
| US-20090199352-A1 | METHOD OF MODULATING STABILITY OF SULFONATED DYE | SILVERBROOK RESEARCH PTY LTD | 2009-08-13 | — | — | US | disclosed |
| WO-2007084445-A2 | SYSTEM AND METHODS FOR AUTOMATIC PREPARATION OF SUBSTITUTE FOOD ITEMS | CANTU HOMARO R (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003470-A1 | INKJET DYES EXHIBITING REDUCED KOGATION | KMT5A, KMT5B, KMT5C | THRB 3499/4885CA12 1183/4885CA2 520/4885 |
| US-12611653-B1 | Nanocomposite for degrading organic contaminants | TDO2, CA4, SCO2 | THRB 1933/4885CA12 298/4885CA2 65/4885 |
| US-12570547-B1 | Copper hydroxide nitrate/calcium silicate/graphitic carbon nitride nanocomposite material based absorbent for wastewater treatment | SOD3, NOS3, SOD1 | THRB 2127/4885CA12 75/4885CA2 11/4885 |
| US-12582972-B1 | Zirconium dioxide/calcium silicate/graphitic carbon nitride nanocomposite and method of use as a photocatalyst | CACNG4, CACNG3, CACNG2 | THRB 3934/4885CA12 222/4885CA2 31/4885 |
| US-20260145971-A1 | METHOD OF WATER PURIFICATION | F7, WRN, CACNA2D2 | THRB 4714/4885CA12 806/4885CA2 877/4885 |
| US-20260097386-A1 | MULTI-NANOCOMPOSITE FOR WATER DECONTAMINATION | VIM, SMYD3, EPCAM | THRB 4775/4885CA12 308/4885CA2 1429/4885 |
| US-12590018-B1 | Nanocomposite for wastewater treatment | CA4, HAO2, SCO2 | THRB 2985/4885CA12 167/4885CA2 21/4885 |
| US-12558666-B1 | Removal of water pollutant using calcium metavanadate/calcium silicate/graphite-phase carbon nitride (CaV2O6/CaSiO3/g-C3N4) nanocomposite | CACNG4, KCNN4, CACNG3 | THRB 4080/4885CA12 171/4885CA2 40/4885 |
| US-20260132059-A1 | HYDROGEN BONDING STABILIZED POLYARYL ORGANIC SOLVENT NANOFILTRATION MEMBRANE | HNRNPF, HNRNPM, UFM1 | THRB 4155/4885CA12 4583/4885CA2 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.